Session

PP 05 IBD (Posters)

PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING
PRELIMINARY DATA ON THE EFFICACY OF USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS IN A 'REAL-WORLD' CLINICAL SETTING

PP 05 IBD (Posters)  et al.

SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE
SUBCUTANEOUS INFLIXIMAB – A REAL WORLD EXPERIENCE

PP 05 IBD (Posters)  et al.

PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY
PREDICTORS OF ANTI-TNF TREATMENT FAILURE IN INFLAMMATORY BOWEL DISEASE PATIENTS NAÏVE TO BIOLOGIC DRUGS: A 20-YEAR REAL WORLD STUDY

PP 05 IBD (Posters)  et al.

UTILITY OF BIOMARKERS IN PREDICTING DISEASE ACTIVITY AND LONG-TERM OUTCOME IN ULCERATIVE COLITIS – A LONGITUDINAL FOLLOW UP STUDY
UTILITY OF BIOMARKERS IN PREDICTING DISEASE ACTIVITY AND LONG-TERM OUTCOME IN ULCERATIVE COLITIS – A LONGITUDINAL FOLLOW UP STUDY

PP 05 IBD (Posters)  et al.

TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY
TWELVE-MONTH OUTCOMES OF TREATMENT WITH USTEKINUMAB IN PATIENTS WITH CROHN’S DISEASE, IN A REAL-LIFE SETTING IN GREECE: INTERIM ANALYSIS OF THE ‘REASSURE’ STUDY

PP 05 IBD (Posters)  et al.

PROPHYLAXIS OF POST-OPERATIVE RELAPSE IN PATIENTS WITH CROHN’S DISEASE; INDICATIONS AND PRACTICE
PROPHYLAXIS OF POST-OPERATIVE RELAPSE IN PATIENTS WITH CROHN’S DISEASE; INDICATIONS AND PRACTICE

PP 05 IBD (Posters)  et al.

REINDUCTION AND INTENSIFICATION STRATEGY WITH USTEKINUMAB IN IBD PATIENTS, A SINGLE CENTER REAL LIFE EXPERIENCE
REINDUCTION AND INTENSIFICATION STRATEGY WITH USTEKINUMAB IN IBD PATIENTS, A SINGLE CENTER REAL LIFE EXPERIENCE

PP 05 IBD (Posters)  et al.

A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS
A BIOMARKER OF EARLY MUCOSAL DESTRUCTION: NEUTROPHIL-MEDIATED TYPE IV COLLAGEN DEGRADATION IS ELEVATED IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS

PP 05 IBD (Posters)  et al.

THE IMPORTANCE OF ANTITNF LEVELS DURING THE INDUCTION IN PERIANAL CROHN´S DISEASE
THE IMPORTANCE OF ANTITNF LEVELS DURING THE INDUCTION IN PERIANAL CROHN´S DISEASE

PP 05 IBD (Posters)  et al.

MAGNETIC RESONANCE IMAGING-BASED MEASURE OF FIBROSIS IN ENTERIC CROHN’S DISEASE
MAGNETIC RESONANCE IMAGING-BASED MEASURE OF FIBROSIS IN ENTERIC CROHN’S DISEASE

PP 05 IBD (Posters)  et al.

REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY
REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY

PP 05 IBD (Posters)  et al.

INFLAMMATORY BOWEL DISEASE IMPACT ON PATIENT’S SEXUAL DESIRE
INFLAMMATORY BOWEL DISEASE IMPACT ON PATIENT’S SEXUAL DESIRE

PP 05 IBD (Posters)  et al.

THE DISAPPEARANCE OF CELL DEATH BRAKES: A NEW MOLECULAR DEFECT IN INFLAMMATORY BOWEL DISEASE (IBD)
THE DISAPPEARANCE OF CELL DEATH BRAKES: A NEW MOLECULAR DEFECT IN INFLAMMATORY BOWEL DISEASE (IBD)

PP 05 IBD (Posters)  et al.

EARLY REAL WORLD EXPERIENCE OF FILGOTINIB FOR TREATMENT OF MODERATE-SEVERE ULCERATIVE COLITIS
EARLY REAL WORLD EXPERIENCE OF FILGOTINIB FOR TREATMENT OF MODERATE-SEVERE ULCERATIVE COLITIS

PP 05 IBD (Posters)  et al.

CROHN'S DISEASE LIKE POUCH INFLAMMATION (CDLPI), IN ILEAL POUCH–ANAL ANASTOMOSIS (IPAA) FOR ULCERATIVE COLITIS (UC), IN A LATIN AMERICAN IBD REFERENCE CENTER
CROHN'S DISEASE LIKE POUCH INFLAMMATION (CDLPI), IN ILEAL POUCH–ANAL ANASTOMOSIS (IPAA) FOR ULCERATIVE COLITIS (UC), IN A LATIN AMERICAN IBD REFERENCE CENTER

PP 05 IBD (Posters)  et al.

DIAGNOSIS METHODS FOR INFLAMMATORY BOWEL DISEASES USING THE FECAL, HEMATOLOGICAL, SEROLOGICAL INDICATORS, FATTY ACIDS' LEVELS OF ERYTHROCYTE MEMBRANES, AND BLOOD SERUM
DIAGNOSIS METHODS FOR INFLAMMATORY BOWEL DISEASES USING THE FECAL, HEMATOLOGICAL, SEROLOGICAL INDICATORS, FATTY ACIDS' LEVELS OF ERYTHROCYTE MEMBRANES, AND BLOOD SERUM

PP 05 IBD (Posters)  et al.

ASSOCIATION OF MICRONUTRIENTS AND SERUM IMMUNOPROTEINS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A PRELIMINARY STUDY
ASSOCIATION OF MICRONUTRIENTS AND SERUM IMMUNOPROTEINS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A PRELIMINARY STUDY

PP 05 IBD (Posters)  et al.

THE CAUDOVIRALES CLASS OF VIRUSES IS ASSOCIATED WITH DENDRITIC CELL IMPAIRMENT IN CD PATIENTS​​​​
THE CAUDOVIRALES CLASS OF VIRUSES IS ASSOCIATED WITH DENDRITIC CELL IMPAIRMENT IN CD PATIENTS​​​​

PP 05 IBD (Posters)  et al.

EFFICACY AND SAFETY OF GRANULOCYTOAPHERESIS IN THE TREATMENT OF STEROID-DEPENDENT AND STEROID-REFRACTORY INFLAMMATORY BOWEL DISEASE
EFFICACY AND SAFETY OF GRANULOCYTOAPHERESIS IN THE TREATMENT OF STEROID-DEPENDENT AND STEROID-REFRACTORY INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

PP 05 IBD (Posters)  et al.

Item 101 - 120 / 826
1 2 3 4 5
6
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42